Vali-Asr Hospital
Arak, Markazi Province, Iran
NCT Number: NCT01764516
This study was carried out with the purpose of evaluating zinc and selenium levels in serum of epileptic patients and compare with normal individuals.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Observational
Arak, Markazi Province, Iran
Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were diagnosed with generalized form of epilepsy by a neurologist for the first time were recruited as cases. The control group (n=40) was selected from healthy individuals, in whom no disease was diagnosed until this study, and were matched to the case group by age, sex, and economical status.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
New generalized and single epileptic cases patients who accept and sign the approval form of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications,
Exclusion criteria
presence of above criteria as well as, generalized and single epileptic cases under treatment
Time frame: 5 months
decrement in serum zinc and selenium level
Time frame: 5 months
Arak University of Medical Sciences
Other
Arak University of Medical Sciences , Ministry of Health and Education,I.R.Iran
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960811
Brain Diseases, Central Nervous System Diseases
Nancy, Lorraine, France
View Trial DetailsNCT06797791
Brain Diseases, Central Nervous System Diseases
Chisinau, Moldova
View Trial DetailsNCT05297695
Brain Diseases, Central Nervous System Diseases
Sohag, Egypt
View Trial DetailsNCT04439656
Absence Epilepsy, Absence Seizures
Orange, California, United States
View Trial Details